Next-Level Neuroscience

Researchers use Single Molecule Counting (SMC®) technology to probe brain biomarkers.

To identify disease biomarkers for the nervous system, scientists must often look beyond cerebrospinal fluid samples, which are difficult to access. Blood is a common noninvasive biomarker source, but neurologic proteins are typically less abundant in blood than brain tissue or cerebrospinal fluid. New ultrasensitive immunoassays measure previously undetectable blood biomarkers, allowing researchers to appreciate small yet important concentration changes. 

Download this ebook from MilliporeSigma to learn how researchers detect neuroscience biomarkers with Single Molecule Counting (SMC®) technology.

Sponsored by